CIHR launches BioCanRX, one of four new Networks of Centres of Excellence (NCE) - Photo Gallery

BioCanRx is receiving $25 million over five years to support collaborative research aimed at developing novel Canadian therapies to fight against cancer. BioCanRX will help accelerate the most promising discoveries from the lab through to proof of concept, manufacturing and clinical testing.

Learn more >>

Date modified: